Skip to main content
. 2024 Feb 13;25(4):2221. doi: 10.3390/ijms25042221

Figure 1.

Figure 1

Description of the therapeutic potential of drugged MSCs as cellular vehicles and/or derived exosomes as cell-free vehicles to deliver anti-tumor compounds.